Aton Ra Partners Intercept Pharmaceuticals, Inc. Transaction History

Aton Ra Partners

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 18, 2023	SELL	$9.17 - $19.29 $11,471 - $24,131	-1,251 Reduced 6.31%	18,581 $205,000
Q1 2023 May 05, 2023	SELL	$12.53 - $21.71 $24,207 - $41,943	-1,932 Reduced 8.88%	19,832 $266,000
Q4 2022 Feb 02, 2023	SELL	$11.61 - $16.11 $68,336 - $94,823	-5,886 Reduced 21.29%	21,764 $269,000
Q3 2022 Nov 14, 2022	BUY	$12.21 - $19.7 $39,474 - $63,690	3,233 Added 13.24%	27,650 $386,000
Q2 2022 Aug 15, 2022	BUY	$11.23 - $19.59 $274,202 - $478,329	24,417 New	24,417 $337,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Aton Ra Partners, based on Form 13F filings with the SEC.

Stay updated on Aton Ra Partners with notifications on news.